Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro

Journal of Bone and Mineral Research

Volumn 17, Issue 10, 2002, Pages 1859-1871

  Collin Osdoby, Patricia ^a   Rothe, Linda ^a   Bekker, Simon ^a   Anderson, Fred ^a   Huang, Yuefang ^a   Osdoby, Philip ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Angiogenesis; Basic FGF; Bone resorption; Chorioallantoic membrane; Osteoclasts

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AMINOGUANIDINE; COLECALCIFEROL; CYCLOOXYGENASE 2 INHIBITOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT COLONY STIMULATING FACTOR 1; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR LIKE EMBRYONIC KINASE; FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE EMBRYONIC KINASE; FLAVONOID; ISOENZYME; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN TYROSINE KINASE; PTGS2 PROTEIN, HUMAN; RECOMBINANT PROTEIN; SULFONAMIDE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CHORIOALLANTOIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CHICK EMBRYO; CHORION; DRUG ANTAGONISM; DRUG EFFECT; DRUG IMPLANT; FETUS MEMBRANE; GENE EXPRESSION REGULATION; GENETICS; HUMAN;

ALLANTOIS; ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; CHICK EMBRYO; CHORION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG IMPLANTS; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; NITROBENZENES; OSTEOCLASTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; SULFONAMIDES;

EID: 0036786256     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.10.1859     Document Type: Article

References (69)

1. Klagsbrun M 1989 The fibroblast growth factor family: Structural and biological properties. Prog Growth Factor Res 1:207-235.
2. Mason I 1994 The ins and outs of fibroblast growth factors. Cell 78:547-552.
3. Bikfalvi A, Klein S, Pintucci G, Rifkin D 1997 Biological roles of fibroblast growth factor-2. Endocr Rev 18:26-45.
4. Basilico C, Moscatelli D 1992 The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165.
5. Klein S, Roghani M, Rifkin D 1997 Fibroblast growth factors as angiogenesis factors: New insights into their mechanism of action. Experientia Suppl 79:159-192.
6. Jackson J, Seed M, Kircher C, Willoughby D, Winkler J 1997 The codependence of angiogenesis and chronic inflammation. FASEB J 11:457-465.
7. Marie P, Debiais F, Cohen-Solal M, de Vernejoul M 2000 New factors controlling bone remodeling. Joint Bone Spine 67:150-156.
8. Boyce B, Hughes D, Wright K, Xing L, Dai A 1999 Recent advances in bone biology provide insight into the pathogenesis of bone diseases. Lab Invest 79:83-94.
9. Goldfarb M 1996 Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7:311-325.
10. Arman E, Haffner-Krausz R, Gorivodsky M, Lonai P 1999 Fgfr2 is required for limb outgrowth and lung-branching morphogenesis. Proc Nad Acad Sci USA 96:11895-11899.
11. Delezoide A, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, Bonaventure J 1998 Spatiotemporal expression of FGFR 1, 2, and 3 genes during human embryo-fetal ossification. Mech Dev 77:19-30.
12. Molteni A, Modrowski D, Hott M, Marie P 1999 Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 24:337-347.
13. Webster M, Donoghue D 1997 FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet 13:178-182.
14. Vajo Z, Francomano C, Wilkin D 2000 The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 21:23-39.
15. Globus R, Plouet J, Gospodarowicz D 1989 Cultured bovine bone cells synthesize fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124:1539-1547.
16. Padera R, Venkataraman G, Berry D, Godavarti R, Sasisekharan R 1999 FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: A compensation model for FGF-2 signaling. FASEB J 13:1677-1687.
17. Mundy G 1999 Cellular and molecular regulation of bone turnover. Bone 24:35S-38S.
18. Czubayko F, Liaudet-Coopman E, Aigner A, Tuveson A, Berchem G, Wellstein A 1997 A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med 3:1137-1140.
19. Rodan S, Wesolowski G, Kyonggeum Y, Rodan G 1989 Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS/17.2 cells. J Biol Chem 264:19934-19941.
20. Debiais F, Hott M, Graulet A, Marie P 1998 The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 13:645-654.
21. Pri-Chen S, Pitaru S, Lokiec F, Savion N 1998 Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23:111-117.
22. Scutt A, Bertram P 1999 Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int 64:69-77.
23. Nakagawa N, Yasuda H, Yano K, Mochizuki S, Kobayashi N, Fujimoto H, Shima N, Morinaga T, Chikazu D, Kawaguchi H, Higashio K 1999 Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. Biochem Biophys Res Commun 265:158-163.
24. Jimi E, Shuto T, Ikebe T, Jingushi S, Hirata M, Koga T 1996 Basic fibroblast growth factor inhibits osteoclast-like cell formation. J Cell Physiol 168:395-402.
25. Kawaguchi H, Chikazu D, Nakamura K, Kumegawa M, Hakeda Y 2000 Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures. J Bone Miner Res 15:466-473.
26. Chikazu D, Hakeda Y, Ogata N, Nemoto K, Itabashi A, Takato T, Kumegawa M, Nakamura K, Kawaguchi H 2000 Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 275:31444-31450.
27. Hurley M, Lee S, Raisz L, Bernecker P, Lorenzo J 1998 Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22:309-316.
28. Pun S, Floria C, Wronski T 2000 Anabolic effects of basic fibroblast growth factor in the tibial diaphysis of ovariectomized rats. Bone 27:197-202.
29. Inui K, Maeda M, Sano A, Fujioka K, Yutani Y, Sakawa A, Yamano Y, Kato Y, Koike T 1998 Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Calcif Tissue Int 63:490-495.
30. Nakamura K, Kurokawa T, Aoyama I, Hanada K, Tamura M, Kawaguchi H 1998 Stimulation of bone formation by intraosseous injection of basic fibroblast growth factor in ovariectomised rats. Int Orthop 22:49-54.
31. Liang H, Pun S, Wronski T 1999 Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology 140:5780-5788.
32. Pun S, Dearden R, Ratkus A, Liang H, Wronski T 2001 Decreased bone anabolic effect of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats. Bone 28: 220-226.
33. Nakamura T, Hara Y, Tagawa M, Tamura M, Yuge T, Fukuda H, Nigi H 1998 Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13:942-949.
34. Iwakura A, Tabata Y, Nishimura K, Nakamura T, Shimizu Y, Fujita M, Komeda M 2000 Basic fibroblast growth factor may improve devascularized sternal healing. Ann Thorac Surg 70: 824-828.
35. Dunstan C, Boyce R, Boyce B, Garrett I 1, Izbicka E, Burgess W, Mundy G 1999 Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized ovariectornized rats. J Bone Miner Res 14:953-959.
36. Kuroda S, Kasugai S, Oida S, Iimura limura R, Ohya K, Ohyama T 1999 Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone. Bone 25:431-437.
37. Amizuka N, Yamada M, Watanabe J, Hoshi K, Fukushi M, Oda K, Ikehara Y, Ozawa H 1998 Morphological examination of bone synthesis via direct administration of basic fibroblast growth factor into rat bone marrow. Microsc Res Tech 41: 313-322.
38. Manabe N, Oda H, Nakamura K, Kuga Y, Uchida S, Kawaguchi H 1999 Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology 38: 714-720.
39. Collin-Osdoby P 1994 Role of vascular endothelial cells in bone biology. J Cell Biochem 55:304-309.
40. Gerber H-P, Vu T, Ryan R, Kowalski J, Werb Z, Ferrera N 1999 VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
41. Koch A 1998 Angiogenesis: Implications for rheumatoid arthritis. Arthrit Rheum 41:951-962.
42. Schwartz Z, Goultschin J, Dean D, Boyan B 1998 Mechanisms of alveolar bone destruction in periodontitis. Periodontol 2000 14:158-172.
43. de Vernejoul MC 1996 Dynamics of bone remodeling: Biochemical and pathophysiological basis. Eur J Clin Chem Clin Biochem 34:729-734.
44. Beck L, D'Amore P 1997 Vascular development: Cellular and molecular regulation. FASEB J 11:365-373.
45. Seghezzi G, Patel S, Ren C, Gualandris A, Pintucci G, Robbins E, Shapiro R, Galloway A, Rifkin D, Mignatti P 1998 Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673.
46. Rusnati M, Tanghetti E, Urbinati C, Tulipano G, Marchesini S, Ziche M, Presta M 1999 Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: Biochemical characterization and biological consequences in endothelial cell cultures. Mol Biol Cell 10:313-327.
47. Cronstein B, Weissman G 1993 The adhesion molecules of inflammation. Arthritis Rheum 36:147-157.
48. Springer T 1994 Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314.
49. Formigli L, Orlandini S, Benvenuti S, Masi L, Pinto A, Gattei V, Bernabei P, Robey P, Collin-Osdoby P, Brandi M 1995 In vitro structural and functional relationships between preosteoclastic and bone endothelial cells: A juxtacrine model for migration and adhesion of osteoclast precursors. J Cell Physiol 162:199-212.
50. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P 2001 Receptor activator of NF-kB ligand and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 276:20659-20672.
51. Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Osdoby P 2000 Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. J Bone Miner Res 15:474-488.
52. Collin-Osdoby P, Oursler M, Rothe L, Webber D, Anderson F, Osdoby P 1995 Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: Relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. J Bone Miner Res 10:45-58.
53. Lowry O, Rosebrough N, Farr A, Randall R 1951 Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
54. Mitchell P, Steenstrup T, Hanon K 1999 Expression of fibroblast growth factor family during postnatal skeletal muscle hypertrophy, J Appl Physiol 86:313-319.
55. Folkman J 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
56. Yamashita A, Yonemitsu Y, Okano S, Nakagawa K, Nakashima Y, Irisa T, Iwamoto Y, Nagai Y, Hasegawa M, Sueishi K 2002 Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J Immunol 168:450-457.
57. Roodman G 1996 Advances in bone biology: The osteoclast. Endocr Rev 17:308-332.
58. Mundy G 1992 Cytokines and local factors which affect osteoclast function. Int J Cell Cloning 10:215-222.
59. Ribatti D, Nico B, Bertossi M, Roncali L, Presta M 1997 Basic fibroblast growth factor-induced angiogenesis in the chick embryo chorioallantoic membrane: An electron microscopy study. Microvasc Res 53:187-190.
60. Parsons-Wingerter P, Elliott KE, Clark JI, Farr AG 2000 Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial trees. Arterioscler Thromb Vasc Biol 20:1250-1256.
61. Friedlander M, Brooks P, Shaffer R, Kincaid C, Varner J, Cheresh D 1995 Definition of two angiogenic pathways by distinct alpha v integrins. Science 270:1500-1502.
62. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA 1998 Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140: 1255-1263.
63. Chang Z, Meyer K, Rapraeger A, Friedl A 2000 Differential ability of heparin sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J 14: 137-144.
64. Ramoshebi L, Ripamonti U 2000 Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-β1. Anat Rec 259:97-107.
65. Kage K, Fujita N, Oh-hara T, Ogata E, Fujita T, Tsuruo T 1999 Basic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone. Biochem Biophys Res Commun 254:259-263.
66. Rak J, Kerbel R 1997 bFGF and tumor angiogenesis-back in the limelight? Nat Med 3:1083-1084.
67. Walsh D, Pearson C 2001 Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 3:147-153.
68. Thornton M, O'Sullivan G, Williams M, Hughes P 1997 Avascular necrosis of bone following an intensified chemotherapy regimen including high dose steroids. Clin Radiol 52:607-612.
69. Glowacki J 1998 Angiogenesis in fracture repair. Clin Orthop 355(Suppl):S82-S89.